ASCVD
Clinical trials for ASCVD explained in plain language.
Never miss a new study
Get alerted when new ASCVD trials appear
Sign up with your email to follow new studies for ASCVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Text reminders may boost statin refills in heart patients
Disease control OngoingThis study will test whether sending reminders by text, email, or secure patient portal messages helps people with heart disease or diabetes refill their statin prescriptions. About 22,000 adults who have not refilled their statin in the last 3 months will receive one of these me…
Matched conditions: ASCVD
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New study aims to boost cholesterol treatment in heart disease patients
Disease control By invitation onlyThis study looks at different methods to help patients with high cholesterol and heart disease get the right medicines to lower their cholesterol. About 300 adults at high risk will take part. The goal is to see which approach helps more people reach their target LDL cholesterol …
Matched conditions: ASCVD
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Computer alert aims to boost cholesterol treatment in heart patients
Disease control OngoingThis study tests whether an electronic alert in the medical record can help doctors prescribe better cholesterol-lowering medications for heart disease patients with high LDL. About 400 patients from a single hospital will be randomly assigned to have their doctor receive the ale…
Matched conditions: ASCVD
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a gentler cholesterol combo prevent diabetes in heart patients?
Disease control By invitation onlyThis study looks at 4,000 adults with prediabetes and heart disease to see if a low-intensity statin combined with ezetimibe is better than a high-intensity statin alone at preventing new diabetes. Participants will be followed to track diabetes development and heart health. The …
Matched conditions: ASCVD
Phase 4 • Sponsor: Seung-Whan Lee, M.D., Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Tracking blood markers over time may reveal hidden heart risk
Knowledge-focused OngoingResearchers at University Hospital Freiburg are studying how blood levels of hsCRP and Lp(a), two markers linked to heart disease, change over time in patients who have had these tests more than once. The study asks whether a high result on a first test often returns to normal la…
Matched conditions: ASCVD
Sponsor: University Hospital Freiburg • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC